Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company is engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Currently, Amylin produces two drugs, Symlin (pramlintide acetate) and Byetta (exenatide). Amylin also is working on producing a drug based on Leptin.
Source: Wikipedia
Campaign Finance
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.
Latest FEC Data
covers through committee's June 30, 2012 filing.-
Summary
overview of the committee's finances- Total Raised:
- $54,203
- Total Spent:
- $37,576
- Cash on Hand:
- $67,583
- Debts:
- $0
Standardized Donation Information
covers through 2011. may lag behind FEC section above, as donors and industries are identified by hand.-
Top Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
-
Republicans vs. Democrats
in dollars -
State vs. Federal
in dollars -
Top PAC Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
Lobbying
$720,000 SpentFigures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying On Behalf of Amylin Pharmaceuticals
-
Names of Lobbyists
-
Firm Hired Amount Podesta Group $150,000 Compass Consulting Group $50,000 Jeffrey J Kimbell & Assoc $40,000 -
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Copyright, Patent & Trademark,
- Pharmacy,
- Medicare & Medicaid,
- Medical Research & Clin Labs,
- Fed Budget & Appropriations
-
Most Frequently Disclosed Bills
Bill No. Title H.R.3590 Service Members Home Ownership Tax Act of 2009 H.R.4213 Tax Extenders Act of 2009